Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-10 @ 10:40 AM
Study NCT ID:
NCT03188458
Status:
TERMINATED
Last Update Posted:
2019-02-12
First Post:
2017-05-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-22
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-19
First Submit QC Date:
None
Study First Post Date:
2017-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-10
Last Update Post Date:
2019-02-12
Last Update Post Date Type:
ACTUAL